1. Home
  2. Search

Search

Search results

143 results found

Alison R. Barton

Person: Ph.D. Student, Harvard Medical School Bioinformatics and Integrative Genomics (BIG), -> Postdoctoral Fellow, Harvard Medical School Department of Genetics
Alison joined the lab as a PhD candidate in Bioinformatics and Integrative Genomics at Harvard University. She previously studied Molecular, Cellular, and Developmental Biology and Archaeological Studies at Yale College. After undergrad, she went on to earn an MPhil in genetics at Cambridge...

Alison Barton has joined the lab!

News: December 10, 2018
Alison is a PhD candidate in the Harvard Medical School BIG program and is interested in studying the role of human genetic variation and population history in health and disease. Welcome, Alison!

Ronen Mukamel has joined the lab!

News: January 14, 2019
Ronen is an Instructor at Harvard Medical School and is interested in structural variation in human genomes and its effects on human health. Welcome, Ronen!

Whole-exome imputation paper published in Nature Genetics

News: July 05, 2021
Alison Barton's paper on whole-exome imputation and subsequent association and fine-mapping analyses in UK Biobank ( Barton et al. 2021 Nat Genet) is now published -- congratulations, Alison! Imputation is a statistical approach that leverages genetic data from a reference panel to enable analysis...

Two clonal hematopoiesis papers published in Nature

News: June 24, 2020
Our papers exploring mosaic chromosomal alterations in UK Biobank ( N~500K; Loh et al. 2020 Nature) and BioBank Japan ( N~200K; Terao et al. 2020 Nature) are now online at Nature. Highlights of these studies include discovery of several new risk loci at which acquired mutations systematically...

New preprint on learning patterns of somatic mutation in cancer

News: August 04, 2021
We are excited to share a new preprint, " Learning the mutational landscape of the cancer genome" (Sherman*, Yaari*, Priebe* et al.). This work, a collaboration with Bonnie Berger's group at MIT, developed a deep-learning model to predict cancer-specific neutral mutation rates at kilobase-scale...